PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Pharmstar Pharmaceuticals, Inc. (PHAR: OTC Link) | Attorney Letter with Respect to Current Information

Category : Stocks

Fri, Mar 08, 2013 04:46 – Pharmstar Pharmaceuticals, Inc. (PHAR: OTC Link) released their Attorney Letter with Respect to Current Information concerning Attorney Opinion Letter for PharmStar Pharmaceuticals, Inc. 2012 Annual Report.. To read the complete report, please visit: https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=100721.

More: Pharmstar Pharmaceuticals, Inc. (PHAR: OTC Link) | Attorney Letter with Respect to Current Information

Post to Twitter

Taisho Pharmaceuticals (TSOPF: Grey Market) | Deleted Symbol

Category : Stocks

Mon, Mar 04, 2013 12:00 – Taisho Pharmaceuticals (TSOPF: Grey Market) – Deleted Symbol – As of Mon, Mar 04, 2013, TSOPF is no longer a valid symbol. You may find a complete list of deleted symbols at otcmarkets.com.

Read more: Taisho Pharmaceuticals (TSOPF: Grey Market) | Deleted Symbol

Post to Twitter

Oramed Pharmaceuticals, Inc. (ORMPD: Nasdaq) | Venue Change

Category : Stocks

Mon, Feb 11, 2013 12:00 – Oramed Pharmaceuticals, Inc. (ORMPD: Nasdaq) – Venue Change – The symbol, ORMPD, no longer trades on OTC Link. As of Mon, Feb 11, 2013, ORMPD trades on Nasdaq. You may find a complete list of venue changes at otcmarkets.com.

More: Oramed Pharmaceuticals, Inc. (ORMPD: Nasdaq) | Venue Change

Post to Twitter

Aeolus Pharmaceuticals, Inc. (AOLS: OTC Link) | Venue Change

Category : Stocks, World News

Fri, Jan 18, 2013 12:00 – Aeolus Pharmaceuticals, Inc. (AOLS: OTC Link) – Venue Change – The symbol, AOLS, no longer trades on OTC Link/FINRA BB. As of Fri, Jan 18, 2013, AOLS trades on OTC Link. You may find a complete list of venue changes at otcmarkets.com.

Read more: Aeolus Pharmaceuticals, Inc. (AOLS: OTC Link) | Venue Change

Post to Twitter

China Pharmaceuticals, Inc. (CFMIE: OTC Link) | Venue Change

Category : Stocks, World News

Mon, Dec 24, 2012 12:00 – China Pharmaceuticals, Inc. (CFMIE: OTC Link) – Venue Change – The symbol, CFMIE, no longer trades on OTC Link/FINRA BB. As of Mon, Dec 24, 2012, CFMIE trades on OTC Link. You may find a complete list of venue changes at otcmarkets.com.

More: China Pharmaceuticals, Inc. (CFMIE: OTC Link) | Venue Change

Post to Twitter

Momenta Pharmaceuticals (MNTA) says the U.S. Court of Appeals has issued its opinion supporting its previous decision to stay the preliminary injunction in the case against Amphastar Pharmaceuticals, Watson Pharmaceuticals (WPI) and International…

Category : World News

Momenta Pharmaceuticals (MNTA) says the U.S. Court of Appeals has issued its opinion supporting its previous decision to stay the preliminary injunction in the case against Amphastar Pharmaceuticals, Watson Pharmaceuticals (WPI) and International Medical Systems. MNTA CEO Craig Wheeler notes the opinion is a setback for the company and has “potentially wide ranging implications for all patent holders.” Shares +3.6% AH. Post your comment!

Read this article: Momenta Pharmaceuticals (MNTA) says the U.S. Court of Appeals has issued its opinion supporting its previous decision to stay the preliminary injunction in the case against Amphastar Pharmaceuticals, Watson Pharmaceuticals (WPI) and International…

Post to Twitter

Arena surges on weight loss drug approval

Category : Business, Stocks

Little-known Arena Pharmaceuticals just got a big boost from the FDA, which gave its stamp of approval on the company’s weight loss drug, known as Belviq.

See more here: Arena surges on weight loss drug approval

Post to Twitter

Big-Cap Health Care Winners

Category : Business, Stocks

NEW YORK (Real Money) — A couple times a week, I check my sector scans to get a sense of which are home to the largest number of top-performing stocks. For the past several weeks, the number of companies from the health care sector has far outweighed the runner-up consumer sector.

Earlier this week, I wrote about a couple of smaller stocks with charts showing some potential, but the leaders run the gamut when it comes to market cap.

One longtime standout that remains a winner is Alexion Pharmaceuticals, which is up 30% so far this year. Between July and March, the stock notched gains every month. It’s not surprising to see the shares finally in consolidation mode, having pulled back from their March 23 all-time high of $95.01. …

Click to view a price quote on ISRG.

Click to research the Health Services industry.

See the original post here: Big-Cap Health Care Winners

Post to Twitter

Investing in U.S. health spending? Think J&J

Category : Business

A new CEO, Alex Gorsky, is taking over this giant maker of pharmaceuticals and other health products. Job one: Improve Johnson & Johnson’s quality control.

More here: Investing in U.S. health spending? Think J&J

Post to Twitter

AMAG Pharmaceuticals, Inc. (AMAG): Q1 EPS of -$0.58 beats by $0.03. Revenue of $15.5M (+15.7% Y/Y). (PR)

Category : Stocks

AMAG Pharmaceuticals, Inc. (AMAG): Q1 EPS of -$0.58 beats by $0.03. Revenue of $15.5M (+15.7% Y/Y). (PR) Post your comment!

Visit link: AMAG Pharmaceuticals, Inc. (AMAG): Q1 EPS of -$0.58 beats by $0.03. Revenue of $15.5M (+15.7% Y/Y). (PR)

Post to Twitter